HURATuHURA Biosciences, Inc./NVvs its industry peers
A metric-by-metric comparison of TuHURA Biosciences, Inc./NV against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HURAEsta | $111M#8 | — | 6.0x#5 | — | — | -34.8%#7 | — | -167.6%#5 | -0.1%#1 | — | -30.9%#3 | — |
| CUE | $140M#1 | — | 60.5x#6 | 5.1x#2 | 195.7%#2 | 34.6%#1 | -96.7%#1 | -1151.6%#6 | — | — | -14.5%#2 | — |
| ZNTL | $137M#2 | — | 1.0x#2 | — | -100.0%#4 | 17.4%#3 | — | -95.4%#4 | — | — | 32.3%#1 | — |
| SCNX | $131M#3 | — | 2.0x#4 | 304.5x#5 | 215.9%#1 | -404.5%#8 | -9867.9%#5 | -64.8%#3 | -73.5%#3 | 4#1 | -81.6%#6 | 11.3%#1 |
| SPRB | $127M#5 | — | 1.5x#3 | — | -100.0%#4 | 26.5%#2 | — | -46.5%#2 | — | — | -58.0%#4 | — |
| FHTX | $127M#4 | — | — | 4.1x#1 | 36.8%#3 | 14.2%#4 | -279.5%#2 | — | — | — | — | — |
| CATX | $115M#7 | — | 0.4x#1 | 80.4x#4 | — | -30.1%#6 | -7919.4%#4 | -31.8%#1 | -41.0%#2 | — | -61.2%#5 | — |
| NERV | $116M#6 | — | — | — | — | -20492.7%#9 | — | — | — | — | — | — |
| NRXP | $93M#9 | — | — | 76.2x#3 | — | -13.9%#5 | -1324.4%#3 | — | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-11-03.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice